215 related articles for article (PubMed ID: 33963463)
1. The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.
Crook A; Kwa R; Ephraums S; Wilding M; Thiyagarajan L; Fleming J; Moore K; Berman Y
Fam Cancer; 2022 Apr; 21(2):241-253. PubMed ID: 33963463
[TBL] [Abstract][Full Text] [Related]
2. Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1.
Wilding M; Fleming J; Moore K; Crook A; Reddy R; Choi S; Schlub TE; Field M; Thiyagarajan L; Thompson J; Berman Y
Fam Cancer; 2023 Oct; 22(4):499-511. PubMed ID: 37335380
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
[TBL] [Abstract][Full Text] [Related]
4. Age-specific risk of breast cancer in women with neurofibromatosis type 1.
Seminog OO; Goldacre MJ
Br J Cancer; 2015 Apr; 112(9):1546-8. PubMed ID: 25742481
[TBL] [Abstract][Full Text] [Related]
5. NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program.
Maani N; Westergard S; Yang J; Scaranelo AM; Telesca S; Thain E; Schachter NF; McCuaig JM; Kim RH
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31121919
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area.
Wang X; Levin AM; Smolinski SE; Vigneau FD; Levin NK; Tainsky MA
Am J Med Genet A; 2012 Dec; 158A(12):3061-4. PubMed ID: 22965642
[TBL] [Abstract][Full Text] [Related]
8. Breast density in NF1 women: a retrospective study.
De Santis R; Cagnoli G; Rinaldi B; Consonni D; Conti B; Eoli M; Liguori A; Cosentino M; Carrafiello G; Garrone O; Giroda M; Cesaretti C; Sfondrini MS; Gambini D; Natacci F
Fam Cancer; 2024 Mar; 23(1):35-40. PubMed ID: 38270845
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors.
Uusitalo E; Kallionpää RA; Kurki S; Rantanen M; Pitkäniemi J; Kronqvist P; Härkönen P; Huovinen R; Carpen O; Pöyhönen M; Peltonen S; Peltonen J
Br J Cancer; 2017 Jan; 116(2):211-217. PubMed ID: 27931045
[TBL] [Abstract][Full Text] [Related]
10. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening.
Sharif S; Moran A; Huson SM; Iddenden R; Shenton A; Howard E; Evans DG
J Med Genet; 2007 Aug; 44(8):481-4. PubMed ID: 17369502
[TBL] [Abstract][Full Text] [Related]
11. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
[TBL] [Abstract][Full Text] [Related]
12. Dysfunctional coping is related to impaired skin-related quality of life and psychological distress in patients with neurofibromatosis type 1 with major skin involvement.
Bottesi G; Spoto A; Trevisson E; Zuccarello D; Vidotto G; Cassina M; Clementi M
Br J Dermatol; 2020 Jun; 182(6):1449-1457. PubMed ID: 31329288
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of the psychological consequences of false-positive screening mammograms.
Bond M; Pavey T; Welch K; Cooper C; Garside R; Dean S; Hyde C
Health Technol Assess; 2013 Mar; 17(13):1-170, v-vi. PubMed ID: 23540978
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the ophthalmological examinations in neurofibromatosis type 1. Proposal for a new screening algorithm.
Caen S; Cassiman C; Legius E; Casteels I
Eur J Paediatr Neurol; 2015 Jul; 19(4):415-22. PubMed ID: 25797697
[TBL] [Abstract][Full Text] [Related]
15. Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).
Wiener L; Battles H; Bedoya SZ; Baldwin A; Widemann BC; Pao M
J Genet Couns; 2018 Feb; 27(1):115-123. PubMed ID: 28735371
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of breast cancer in women with NF1.
Madanikia SA; Bergner A; Ye X; Blakeley JO
Am J Med Genet A; 2012 Dec; 158A(12):3056-60. PubMed ID: 23165953
[TBL] [Abstract][Full Text] [Related]
17. Psychological impact of breast cancer screening in Japan.
Kitano A; Yamauchi H; Hosaka T; Yagata H; Hosokawa K; Ohde S; Nakamura S; Takimoto M; Tsunoda H
Int J Clin Oncol; 2015 Dec; 20(6):1110-6. PubMed ID: 26007689
[TBL] [Abstract][Full Text] [Related]
18. Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress.
van Erkelens A; Sie AS; Manders P; Visser A; Duijm LE; Mann RM; Ten Voorde M; Kroeze H; Prins JB; Hoogerbrugge N
Eur J Cancer; 2017 Jun; 78():45-52. PubMed ID: 28412588
[TBL] [Abstract][Full Text] [Related]
19. Characterization of health concerns in people with neurofibromatosis type 1.
Fleming J; Morgan O; Wong C; Schlub TE; Berman Y
Mol Genet Genomic Med; 2023 Jan; 11(1):e2077. PubMed ID: 36444392
[TBL] [Abstract][Full Text] [Related]
20. Appearance concerns among women with neurofibromatosis: examining sexual/bodily and social self-consciousness.
Smith KB; Wang DL; Plotkin SR; Park ER
Psychooncology; 2013 Dec; 22(12):2711-9. PubMed ID: 23873824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
